Activation and trafficking of peritoneal B1a B-cells in response to amphibole asbestos

Journal of Immunotoxicology

Volumn 11, Issue 1, 2014, Pages 90-98

  Pfau, Jean C ^a   Hurley, Kristina ^b   Peterson, Cody ^a   Coker, Lindsey ^a   Fowers, Cody ^a   Marcum, Ryan ^a  

^a IDAHO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

, B cells; Alpha 4 ( 4) integrin; Asbestos; Libby amphibole; Mouse model; Peritoneal; Pleural

Indexed keywords

ALPHA4 INTEGRIN; AMPHIBOLE; CD45 ANTIGEN; CD5 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B1A B LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOPATHOLOGY; IN VITRO STUDY; LYMPH NODE CELL; LYMPHOID TISSUE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM CELL; PLEURA CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; ANIMAL; C57BL MOUSE; CASE REPORT; CELL CULTURE; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; METABOLISM; PATHOLOGY; PERITONEUM; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ASBESTOS, AMPHIBOLE; B-LYMPHOCYTES; B-LYMPHOCYTES, REGULATORY; CELL MOVEMENT; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN ALPHA4; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PERITONEUM;

EID: 84896496544     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2013.796024     Document Type: Article

References (46)

1. Antao, V. C., Larson, T. C., and Horton, D. K. 2012. Libby vermiculite exposure and risk of developing asbestos-related lung and pleural diseases. Curr. Opin. Pulm. Med. 18:161-167.
2. Atencio, S., Amano, H., Izui, S., and Kotzin, B. L. 2004. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. J. Immunol. 172:4159-4166.
3. Aust, A. E., Cook, P. M., and Dodson, R. F. 2011. Morphological and chemical mechanisms of elongated mineral particle toxicities. J. Toxicol. Environ. Health 14:40-75.
4. Bamba, H., Ishigaki, H., Ishida, H., et al. 2005. B1-B-cells are the main antigen-presenting cells in CpG-ODN-stimulated peritoneal exudate cells. Microbiol. Immunol. 49:89-95.
5. Berberich, S., Dähne, S., Schippers, A., et al. 2008. Differential molecular and anatomical basis for B-cell migration into the peritoneal cavity and omental milky spots. J. Immunol. 180:2196-2203.
6. Berry, K., and Martinic, G. 2005. Harvesting murine peritoneal cells: A methodology for the untrained research worker. Contemp. Top. Lab. Anim. Sci. 44:50-51.
7. Bouaziz, J. D., Yanaba, K., and Tedder, T. F. 2008. Regulatory B-cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224: 201-214.
8. Broaddus, V. C., Everitt, J. I., Black, B., and Kane, A. B. 2011. Non-neoplastic and neoplastic pleural endpoints following fiber exposure. J. Toxicol. Environ. Health 14:153-178.
9. Bunderson-Schelvan, M., Pfau, J. C., Crouch, R., and Holian, A. 2011. Non-pulmonary outcomes of asbestos exposure. J. Toxicol. Env. Health 14:122-152.
10. DeLillo, D. J., Matsushita, T., and Tedder, T. F. 2009. B10 cells and regulatory B-cells balance immune responses during inflammation, autoimmunity, and cancer. Ann. NY Acad. Sci. 1183:38-57.
11. Enghard, P., Humrich, J. Y., Chu, V. T., et al. 2010. Class switching and consecutive loss of dsDNA-reactive B1a B-cells from the peritoneal cavity during murine lupus development. Eur. J. Immunol. 40: 1809-1818.
12. Fagarasan, S., Watanabe, N., Honjo, T. 2000. Generation, expansion, migration and activation of mouse B1 cells. Immunol. Rev. 176: 205-215.
13. Gronwall, C., Vas, J., and Silverman, G. J. 2012. Protective roles of natural IgM antibodies. Front. Immunol. 3:66.
14. Ha, S. A., Tsuji, M., Suzuki, K., et al. 2006. Regulation of B1 cell migration by signals through Toll-like receptors. J. Exp. Med. 203: 2541-2550.
15. Hillion, S., Rochas, C., Youinou, P., and Jamin, C. 2005. Expression and reexpression of recombination activating genes: Relevance to development of autoimmune states. Ann. NY Acad. Sci. 1050:10-18.
16. Ishida, D., Su, L., Tamura, A., et al. 2006. Rap1 signal controls B-cell receptor repertoire and generation of self-reactive B1a cells. Immunity 24:417-427.
17. Ishida, H., Hastings, R., Kearney, J., and Howard, M. 1992. Continuous anti-IL-10 antibody administration depletes mice of Ly-1 B-cells but not conventional B-cells. J. Exp. Med. 175:1213-1220.
18. Kaminski, D. A., and Stavnezer, J. 2006. Enhanced IgA class switching in marginal zone and B1 B-cells relative to follicular/B2 B-cells. J. Immunol. 177:6025-6029.
19. Kane, A. B. 1992. Animal models of mesothelioma induced by mineral fibers: Implications for human risk assessment. Prog. Clin. Biol. Res. 374:37-50.
20. Kendall, P. L., Woodward, E. J., Hulbert, C., and Thomas, J. W. 2004. Peritoneal B-cells govern the outcome of diabetes in non-obese diabetic mice. Eur. J. Immunol. 34:2387-2395.
21. Larson, T. C., Meyer, C. A., Kapil, V., et al. 2010. Workers with Libby amphibole exposure: retrospective identification and progresssion of radiographic changes. Radiology 255:924-933.
22. Lau, C. M., Broughton, C., Tabor, A. S., et al. 2005. RNA-associated autoantigens activate B-cells by combined B-cell antigen receptor/Tolllike receptor 7 engagement. J. Exp. Med. 202:1171-1177.
23. Marchand, D. L., St-Hilaire, S., Putnam, E. A., et al. 2012. Mesothelial cell and anti-nuclear autoantibodies associated with pleural abnormalities in an asbestos exposed population of Libby MT. Toxicol. Lett. 208:168-173.
24. Martin, F., and Kearney, J. F. 2001. B1 cells: Similarities and differences with other B-cell subsets. Curr. Opin. Immunol. 13:195-201.
25. Mohan, C., Morel, L., Yang, P., and Wakeland, E. K. 1998. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum. 41:1652-1662.
26. Morbach, H., Singh, S. K., Faber, C., et al. 2006. Analysis of RAG expression by peripheral blood CD5\+ and CD5-B-cells of patients with childhood systemic lupus erythematosus. Ann. Rheum. Dis. 65: 482-487.
27. Murakami, M., Tsubata, T., Shinkura, R., et al. 1994. Oral administration of lipopolysaccharide activates B-1 cells in the peritoneal cavity and lamina propria of gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J. Exp. Med. 180:111-121.
28. Murakami, M., and Honjo T. 1995. Involvement of B-1 cells in mucosal immunity and auto-immunity. Immunol. Today 16:534-539.
29. Murakami, M., Yoshioka, H., Shirai, T., et al. 1995. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 7:877-882.
30. Noonan, C. W., Pfau, J. C., Larson, T. C., and Spence, M. R. 2006. Nested case-control study of autoimmune disease in an asbestos-exposed population. Environ. Health. Perspect. 114:1243-1247.
31. Peipins, L. A., Lewin, M., Campolucci, S., et al. 2003. Radiographic abnormalities and exposure to asbestos-contaminiated vermiculite in the community of Libby, Montana, USA. Environ. Health Perspect. 111:1753-1759.
32. Pfau, J. C., Blake, D. J., and Fritzler, M. 2009. Autoantibody profiles of an asbestos-exposed population. In: Autoimmunity: Role, Regulation and Disorders (Vogel, F. L., and Zimmerman, L. F., Eds.). New York: Nova Biomedical Books, pp. 245-268.
33. Pfau, J. C., Li, S., Holland, S., and Sentissi, J. J. 2011. Alternation of fibroblast phenotype by asbestos-induced autoantibodies. J. Immunotoxicol. 8:159-169.
34. Pfau, J. C., Sentissi, J. J., Li, S., et al. 2008. Asbestos-induced autoimmunity in C57BL/6 mice. J. Immunotoxicol. 5:129-137.
35. Pfau, J. C., Sentissi, J. J., Weller, G., and Putnam, E. A. 2005. Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA. Environ. Health. Perspect. 113:25-30.
36. Rasmussen, D. L., and Pfau, J. C. 2012. Asbestos activates CH12.LX B-lymphocytes via macro-phage signaling. J. Immunotoxicol. 9: 129-140.
37. Rohs, A. M., Lockey, J. E., Dunning, K. K., et al. 2008. Low-level fiberinduced radiographic changes caused by Libby vermiculite: A 25-year follow-up study. Am. J. Respir. Crit. Care Med. 177:630-637.
38. Sato, T., Ishikawa, S., Akadegawa, K., et al. 2004. Aberrant B1 cell migration into the thymus results in activation of CD4 T-cells through its potent antigen-presenting activity in the development of murine lupus. Eur. J. Immunol. 34:3346-3358.
39. Smartt, A. M., Brezinski, M., Trapkus, M., et al. 2010. Collagen accumulation over time in the murine lung after exposure to crocidolite asbestos or Libby amphibole. Environ. Toxicol. 25:68-76.
40. Tuscano, J. M., Harris, G. S., and Tedder, T. F. 2003. B-Lymphocytes contribute to autoimmune disease pathogenesis: Current trends and clinical implications. Autoimmun. Rev. 2:101-108.
41. Webber, J. S., Blake, D. J., Ward, T. J., and Pfau, J. C. 2008. Separation and characterization of respirable amphibole fibers from Libby, Montana. Inhal. Toxicol. 20:733-740.
42. Xu, Z., Butfiloski, E. J., Sobel, E. S., and Morel, L. 2004. Mechanisms of peritoneal B-1a cells accumulation induced by murine lupus susceptibility locus Sle2. J. Immunol. 173:6050-6058.
43. Yanaba, K., Bouaziz, J. D., Haas, K. M., et al. 2008. A regulatory B-cell subset with a unique CD1dhiCD5\+ phenotype controls T-celldependent inflammatory responses. Immunity 28:639-650.
44. Yang, Y., Tung, J. W., Ghosn, E. E., and Herzenberg, L. A. 2007. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc. Natl. Acad. Sci. USA 104:4542-4546.
45. Youinou, P., and Lydyard, P. M. 2001. CD5\+ B-cells in non-organspecific autoimmune diseases: a fresh look. Lupus 10:523-525.
46. Youinou, P., and Renaudineau, Y. 2007. The paradox of CD5-expressing B-cells in systemic lupus erythematosus. Autoimmun. Rev. 7:149-154.